INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 263 filers reported holding INTELLIA THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.75 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $3,426,000 | +14.7% | 21,157 | -43.2% | 0.08% | +17.9% |
| Q1 2021 | $2,987,000 | +22.1% | 37,225 | -17.2% | 0.07% | +19.6% |
| Q4 2020 | $2,446,000 | +89.2% | 44,963 | -30.9% | 0.06% | +75.0% |
| Q3 2020 | $1,293,000 | -26.5% | 65,031 | -22.3% | 0.03% | -20.0% |
| Q2 2020 | $1,760,000 | +71.9% | 83,737 | 0.0% | 0.04% | +53.8% |
| Q1 2020 | $1,024,000 | +5.5% | 83,737 | +26.5% | 0.03% | +36.8% |
| Q4 2019 | $971,000 | +10.0% | 66,170 | 0.0% | 0.02% | -5.0% |
| Q3 2019 | $883,000 | -55.4% | 66,170 | -45.2% | 0.02% | -56.5% |
| Q2 2019 | $1,978,000 | -4.2% | 120,854 | 0.0% | 0.05% | -6.1% |
| Q1 2019 | $2,064,000 | +41.4% | 120,854 | +13.0% | 0.05% | 0.0% |
| Q4 2018 | $1,460,000 | -7.2% | 106,941 | +94.4% | 0.05% | +8.9% |
| Q3 2018 | $1,574,000 | +4.6% | 55,000 | 0.0% | 0.04% | +25.0% |
| Q2 2018 | $1,505,000 | +29.9% | 55,000 | 0.0% | 0.04% | +12.5% |
| Q1 2018 | $1,159,000 | – | 55,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,216,340 | $62,958,000 | 7.04% |
| Discovery Value Fund | 584,483 | $30,253,000 | 6.33% |
| MPM BioImpact LLC | 299,409 | $15,497,000 | 4.30% |
| ARK Investment Management | 9,514,580 | $439,003,000 | 2.60% |
| Elmwood Wealth Management, Inc. | 67,899 | $3,514,000 | 2.00% |
| Nikko Asset Management Americas, Inc. | 2,781,136 | $141,143,000 | 1.74% |
| Avidity Partners Management LP | 1,125,194 | $58,240,000 | 1.34% |
| Merlin Capital, Inc | 12,174 | $630,000 | 1.26% |
| Atlas Venture Associates IX, LLC | 10,000 | $518,000 | 1.18% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $5,768,000 | 1.16% |